Bioharvest Sciences (BHST) Accumulated Expenses (2023 - 2025)

Bioharvest Sciences has reported Accumulated Expenses over the past 3 years, most recently at $386000.0 for Q4 2025.

  • Quarterly results put Accumulated Expenses at $386000.0 for Q4 2025, down 3.74% from a year ago — trailing twelve months through Dec 2025 was $386000.0 (down 3.74% YoY), and the annual figure for FY2025 was $386000.0, down 3.74%.
  • Accumulated Expenses for Q4 2025 was $386000.0 at Bioharvest Sciences, down from $401000.0 in the prior quarter.
  • Over the last five years, Accumulated Expenses for BHST hit a ceiling of $458000.0 in Q4 2023 and a floor of $386000.0 in Q4 2025.
  • Median Accumulated Expenses over the past 3 years was $401000.0 (2024), compared with a mean of $415000.0.
  • Biggest five-year swings in Accumulated Expenses: fell 12.45% in 2024 and later fell 3.74% in 2025.
  • Bioharvest Sciences' Accumulated Expenses stood at $458000.0 in 2023, then fell by 12.45% to $401000.0 in 2024, then fell by 3.74% to $386000.0 in 2025.
  • The last three reported values for Accumulated Expenses were $386000.0 (Q4 2025), $401000.0 (Q4 2024), and $458000.0 (Q4 2023) per Business Quant data.